MIDAS VERDICT:

The NHS, like many other health services, has been slow to respond to the digital revolution. This is expected to change – and fast – as the Covid19 pandemic has accelerated the use of technology on and off the ward. Induction Healthcare is a young business and probably not for the most cautious investor. But at 99p, the shares are worth a punt for longer-term, more seasoned investors. Those wanting to help the NHS become even better than it is already may also want to snap up some stock.